检索结果 - Richard Torstenson
- Showing 1 - 7 results of 7
-
1
-
2
Defining Improvement in Nonalcoholic Steatohepatitis for Treatment Trial Endpoints: Recommendations From the Liver Forum 由 Amanda Cheung, Brent A. Neuschwander‐Tetri, David E. Kleiner, Elmer Schabel, Mary E. Rinella, Stephen A. Harrison, Vlad Ratziu, Arun J. Sanyal, Rohit Loomba, S. Megnien, Richard Torstenson, Veronica Miller
出版 2019Revisão -
3
Comparison of ADAPT, FIB-4 and APRI as non-invasive predictors of liver fibrosis and NASH within the CENTAUR screening population 由 Mette Juul Nielsen, Diana Julie Leeming, Zachary Goodman, Scott L. Friedman, Peder Frederiksen, Daniel Guldager Kring Rasmussen, Pamela Vig, Star Seyedkazemi, Laurent Fischer, Richard Torstenson, M.A. Karsdal, Éric Lefebvre, Arun J. Sanyal, Vlad Ratziu
出版 2021Artigo -
4
NAFLD and NASH biomarker qualification in the LITMUS consortium – Lessons learned 由 Daniel Guldager Kring Rasmussen, Quentin M. Anstee, Richard Torstenson, Bruno Golding, Scott D. Patterson, Clifford A. Brass, Paresh Thakker, Stephen A. Harrison, Andrew N. Billin, Detlef Schuppan, Jean‐François Dufour, Anneli Andersson, Ioan Wigley, Elizabeth Shumbayawonda, Andrea Dennis, Corinna Schoelch, Vlad Ratziu, Carla Yunis, Patrick M. Bossuyt, M.A. Karsdal
出版 2022Revisão -
5
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease 由 Timothy Hardy, Kristy Wonders, Ramy Younes, Guruprasad P. Aithal, R. Aller, Michael Allison, Pierre Bédossa, Fay Betsou, Jérôme Boursier, M. Julia Brosnan, Alastair D. Burt, Jeremy Cobbold, Helena Cortez‐Pinto, Chris Day, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Stephen A. Harrison, Luca Miele, Patrik Nasr, George Papatheodoridis, Salvatore Petta, Dina Tiniakos, Richard Torstenson, Luca Valenti, Adriaan G. Holleboom, Hannele Yki‐Järvinen, Andreas Geier, Manuel Romero‐Gómez, Vlad Ratziu, Elisabetta Bugianesi, Jörn M. Schattenberg, Quentin M. Anstee
出版 2020Artigo -
6
Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study 由 Yasaman Vali, Jenny Lee, Jérôme Boursier, Salvatore Petta, Kristy Wonders, Dina Tiniakos, Pierre Bédossa, Andreas Geier, Sven Francque, Mike Allison, George Papatheodoridis, Helena Cortez‐Pinto, Raluca Pais, Jean‐François Dufour, Diana Julie Leeming, Stephen A. Harrison, Yu Chen, Jeremy Cobbold, Michael Pavlides, Adriaan G. Holleboom, Hannele Yki‐Järvinen, Javier Crespo, M.A. Karsdal, Rachel Ostroff, Mohammad Hadi Zafarmand, Richard Torstenson, Kevin L. Duffin, Carla Yunis, Clifford A. Brass, Mattias Ekstedt, Guruprasad P. Aithal, Jörn M. Schattenberg, Elisabetta Bugianesi, Manuel Romero‐Gómez, Vlad Ratziu, Quentin M. Anstee, Patrick M. Bossuyt
出版 2023Artigo -
7
Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study 由 Jenny Lee, Max Westphal, Yasaman Vali, Jérôme Boursier, Salvatorre Petta, Rachel Ostroff, Leigh Alexander, Yu Chen, Céline Fournier, Andreas Geier, Sven Francque, Kristy Wonders, Dina Tiniakos, Pierre Bédossa, Mike Allison, George Papatheodoridis, Helena Cortez‐Pinto, Raluca Pais, Jean‐François Dufour, Diana Julie Leeming, Stephen Harrison, Jeremy Cobbold, Adriaan G. Holleboom, Hannele Yki‐Järvinen, Javier Crespo, Mattias Ekstedt, Guruprasad P. Aithal, Elisabetta Bugianesi, Manuel Romero‐Gómez, Richard Torstenson, M.A. Karsdal, Carla Yunis, Jörn M. Schattenberg, Detlef Schuppan, Vlad Ratziu, Clifford A. Brass, Kevin L. Duffin, Aeilko H. Zwinderman, Michael Pavlides, Quentin M. Anstee, Patrick M. Bossuyt
出版 2023Artigo
相关主题
Medicine
Internal medicine
Disease
Fatty liver
Gastroenterology
Pathology
Steatohepatitis
Chemistry
Environmental health
Fibrosis
Intensive care medicine
Litmus
Nonalcoholic fatty liver disease
Nonalcoholic steatohepatitis
Physical chemistry
Population
Abdominal pain
Algorithm
Alternative medicine
Anesthesia
Artificial intelligence
Biochemistry
Biology
Biomarker
Biopsy
Boosting (machine learning)
Chronic constipation
Chronic liver disease
Cirrhosis
Clinical trial